Yazi D. Ke

5.7k total citations · 1 hit paper
57 papers, 4.2k citations indexed

About

Yazi D. Ke is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Yazi D. Ke has authored 57 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 22 papers in Molecular Biology and 22 papers in Neurology. Recurrent topics in Yazi D. Ke's work include Alzheimer's disease research and treatments (39 papers), Amyotrophic Lateral Sclerosis Research (17 papers) and Neuroscience and Neuropharmacology Research (14 papers). Yazi D. Ke is often cited by papers focused on Alzheimer's disease research and treatments (39 papers), Amyotrophic Lateral Sclerosis Research (17 papers) and Neuroscience and Neuropharmacology Research (14 papers). Yazi D. Ke collaborates with scholars based in Australia, United States and Switzerland. Yazi D. Ke's co-authors include Lars M. Ittner, Jürgen Götz, Janet van Eersel, Mian Bi, Fabien Delerue, Amadeus Gladbach, Matthias Staufenbiel, Anne Eckert, Ian A. Napier and Edna C. Hardeman and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yazi D. Ke

56 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

2010 1.4k citations Lars M. Ittner, Yazi D. Ke et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yazi D. Ke Australia	28	2.6k	1.6k	1.4k	850	781	57	4.2k
Selina Wray United Kingdom	33	2.4k 0.9×	2.1k 1.3×	1.2k 0.8×	1.0k 1.2×	1.0k 1.3×	75	4.7k
Guilian Xu United States	25	2.4k 0.9×	1.4k 0.9×	1.0k 0.8×	922 1.1×	921 1.2×	49	4.2k
Annakaisa Haapasalo Finland	36	2.0k 0.8×	2.1k 1.3×	1.4k 1.1×	862 1.0×	690 0.9×	109	5.3k
Sarah L. DeVos United States	22	2.6k 1.0×	1.6k 1.0×	1.1k 0.8×	1.1k 1.3×	714 0.9×	24	3.9k
Celeste M. Karch United States	31	2.5k 1.0×	2.0k 1.2×	767 0.6×	1.6k 1.9×	846 1.1×	75	5.0k
Victoria Gonzales United States	16	2.0k 0.8×	1.1k 0.7×	957 0.7×	869 1.0×	699 0.9×	19	3.4k
Wayne W. Poon United States	34	2.5k 1.0×	2.2k 1.4×	1.3k 0.9×	1.1k 1.2×	338 0.4×	52	4.7k
Laurent Pradier France	39	2.9k 1.1×	2.6k 1.6×	1.8k 1.3×	777 0.9×	575 0.7×	98	5.2k
Tamara Ratovitski United States	23	1.9k 0.7×	2.0k 1.2×	1.4k 1.0×	463 0.5×	421 0.5×	32	3.5k
Diederik Moechars Belgium	28	1.9k 0.7×	1.3k 0.8×	1.1k 0.8×	930 1.1×	480 0.6×	53	3.8k

Countries citing papers authored by Yazi D. Ke

Since Specialization

Citations

This map shows the geographic impact of Yazi D. Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazi D. Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazi D. Ke more than expected).

Fields of papers citing papers by Yazi D. Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazi D. Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazi D. Ke. The network helps show where Yazi D. Ke may publish in the future.

Co-authorship network of co-authors of Yazi D. Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Yazi D. Ke. A scholar is included among the top collaborators of Yazi D. Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazi D. Ke. Yazi D. Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hummel, Annika van, Miheer Sabale, Magdalena Przybyla, et al.. (2023). TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models. Neuropathology and Applied Neurobiology. 49(2). e12902–e12902. 4 indexed citations

Martínez‐Mármol, Ramón, Rosina Giordano-Santini, Ann‐Na Cho, et al.. (2023). SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Science Advances. 9(23). eadg2248–eadg2248. 41 indexed citations

Asih, Prita R., Anne Poljak, Michael Kassiou, Yazi D. Ke, & Lars M. Ittner. (2022). Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant. PLoS ONE. 17(5). e0254296–e0254296. 2 indexed citations

Eersel, Janet van, et al.. (2022). Recent progress in synthetic self-adjuvanting vaccine development. Biomaterials Science. 10(15). 4037–4057. 9 indexed citations

Phan, Katherine, Ying He, YuHong Fu, et al.. (2021). Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia. SHILAP Revista de lepidopterología. 1(1). 22 indexed citations

Ippati, Stefania, Yuanyuan Deng, Julia van der Hoven, et al.. (2021). Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity. Proceedings of the National Academy of Sciences. 118(12). 23 indexed citations

Bright, Fiona, et al.. (2021). TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. International Journal of Molecular Sciences. 22(15). 7781–7781. 41 indexed citations

Ittner, Arne, Prita R. Asih, Josefine Bertz, et al.. (2020). Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ. Acta Neuropathologica. 140(3). 279–294. 26 indexed citations

Ke, Yazi D., Kristie Stefanoska, Carol G. Au, et al.. (2019). CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation. Journal of Biological Chemistry. 294(38). 14149–14162. 10 indexed citations

10.

Hummel, Annika van, Julia van der Hoven, Marco Morsch, et al.. (2018). Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. American Journal Of Pathology. 188(6). 1447–1456. 7 indexed citations

11.

Ahmed, Rebekah M., Yazi D. Ke, Steve Vucic, et al.. (2018). Physiological changes in neurodegeneration — mechanistic insights and clinical utility. Nature Reviews Neurology. 14(5). 259–271. 71 indexed citations

12.

Bi, Mian, Amadeus Gladbach, Janet van Eersel, et al.. (2017). Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nature Communications. 8(1). 473–473. 133 indexed citations

13.

Hummel, Annika van, Mian Bi, Stefania Ippati, et al.. (2016). No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice. PLoS ONE. 11(10). e0163236–e0163236. 29 indexed citations

14.

Gladbach, Amadeus, Janet van Eersel, Mian Bi, Yazi D. Ke, & Lars M. Ittner. (2013). ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke. Journal of Neural Transmission. 121(5). 543–7. 25 indexed citations

15.

Schönrock, Nicole, Yazi D. Ke, David T. Humphreys, Matthias Staufenbiel, & Lars M. Ittner. (2010). Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-b. 3 indexed citations

16.

Ittner, Lars M., Yazi D. Ke, Fabien Delerue, et al.. (2010). Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models. Cell. 142(3). 387–397. 1441 indexed citations breakdown →

17.

Götz, Jürgen, et al.. (2010). Dissecting Toxicity of Tau and β-Amyloid. Neurodegenerative Diseases. 7(1-3). 10–12. 21 indexed citations

18.

Eersel, Janet van, Mian Bi, Yazi D. Ke, et al.. (2009). Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains. Journal of Neural Transmission. 116(10). 1243–1251. 34 indexed citations

19.

Götz, Jürgen, Della David, Frédéric J. Hoerndli, et al.. (2008). Functional Genomics Dissects Pathomechanisms in Tauopathies: Mitosis Failure and Unfolded Protein Response. Neurodegenerative Diseases. 5(3-4). 179–181. 9 indexed citations

20.

Schild, Andreas, Karsten Schmidt, Yun‐An Lim, et al.. (2006). Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation. International Journal of Developmental Neuroscience. 24(7). 437–443. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact